A Substack article will come out every 10 days or so, documenting the data and the journey, stay tuned
Clinical Trial Efficacy Data The approval is backed by two pivotal Phase 3 trials within the CORALreef clinical program evaluated at week 24: CORALreef Lipids Trial: Achieved a statistically significant 56% placebo-adjusted reduction in LDL-C (with a post-hoc analysis showing a 60% reduction when biological inconsistencies were removed)
As Hamblins review of photobiomodulation mechanisms describes, stimulating this enzyme with red (~660nm) and near-infrared (~850nm) light increases ATP production, reduces oxidative stress, and supports growth factors involved in tissue repair
Handgrip strength improved by approximately 4.5 kg at 12 months
Downsides are obvious: large outlays reduce emergency savings and may crowd out essential bills like rent or medical care
"We take great pride in knowing that these scientifically-backed offerings will allow people to live more comfortably, take the guesswork out of daily metabolic health, and ensure they stick to their treatment plan to achieve their desired results." "Our goal was to create products that addressed the side effects of GLP-1 head on, from improved digestive function, to enhanced metabolism and blood sugar support, and better-retained muscle mass," shared Dr